Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Other Accumulated Expenses (2020 - 2025)

Bio-Techne has reported Other Accumulated Expenses over the past 6 years, most recently at $1.6 million for Q4 2025.

  • Quarterly results put Other Accumulated Expenses at $1.6 million for Q4 2025, down 40.05% from a year ago — trailing twelve months through Dec 2025 was $1.6 million (down 40.05% YoY), and the annual figure for FY2025 was $1.6 million, down 23.52%.
  • Other Accumulated Expenses for Q4 2025 was $1.6 million at Bio-Techne, down from $4.5 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for TECH hit a ceiling of $5.5 million in Q4 2021 and a floor of $865000.0 in Q1 2023.
  • Median Other Accumulated Expenses over the past 5 years was $2.6 million (2021), compared with a mean of $2.8 million.
  • Biggest five-year swings in Other Accumulated Expenses: tumbled 75.87% in 2022 and later soared 240.92% in 2024.
  • Bio-Techne's Other Accumulated Expenses stood at $5.5 million in 2021, then tumbled by 75.87% to $1.3 million in 2022, then skyrocketed by 220.32% to $4.2 million in 2023, then crashed by 37.7% to $2.6 million in 2024, then plummeted by 40.05% to $1.6 million in 2025.
  • The last three reported values for Other Accumulated Expenses were $1.6 million (Q4 2025), $4.5 million (Q3 2025), and $1.6 million (Q2 2025) per Business Quant data.